In a growing trend, we have seen Pharmacy Services Administrative Organizations (PSAOs) recently undertake new efforts to withhold reimbursements due and owing to pharmacies after they have been terminated by one or more pharmacy benefits managers... Read More
This article examines Pharmacy Benefit Manager’s (“PBM”) “rebate walls” and the impact on the United States drug supply chain. The Federal Trade Commission head, Commissioner Rohit Chopra, recently issued a report on PBM rebate walls,... Read More
As Congress has made changes to the health care system over the past 30 years, nothing has impacted consumers' lives as much as the growth of pharmacy benefit managers (PBMs). Most consumers might not think that PBMs play a large role in their... Read More
As a follow-up to our May 18, 2021 article, the bipartisan piece of legislation that unanimously passed the Texas House and Senate aimed at regulating pharmacy benefit managers (PBMs) was signed into law by Governor Greg Abbott. This is a huge win... Read More
https://youtu.be/sCUAjwc-wdg Frier Levitt’s Jonathan Levitt, Esq. and Lucas Morgan, Esq. talk about PBM Audit Fees in our latest video! Learn about what a PBM audit fee is, what plan sponsors need to know, laws that pharmacies should be aware... Read More
Frier Levitt Partner, Anthony J. Mahajan, Esq. has authored an article in the May 10, 2021 issue of Total Pharmacy titled "Part D Participants Should Validate Audit Processes for Prescription Drug Event Data." The premise of the article... Read More
Frier Levitt successfully lifted a payment suspension imposed by a major Pharmacy Benefit Manager ("PBM") upon an independent pharmacy based in New York. The PBM effectuated the payment suspension shortly after conducting an audit but prior to... Read More
Pharmacy Benefit Managers (PBMs) routinely request pharmacies to submit credentialing when seeking admission into their networks, and require re-credentialing applications to be submitted two to three years after the pharmacies’ admission. The... Read More
A district judge in New Jersey recently permitted the relator in United States ex rel. Silver v. Omnicare Inc., No. 11-cv-01326 (D.N.J. Apr. 13, 2021), to file an amended complaint alleging that a pharmacy’s submission of dispensing data to a Part... Read More
